ReviewPharmacology research & perspectives2024

Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.

Stephen J Nicholls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.